OraVerse phentolamine regulatory update

Regulatory agencies in the U.K., Germany, Italy, France and Spain accepted for review an MAA from Novalar for OraVerse phentolamine for reversal of soft tissue anesthesia following routine dental procedures. The application was submitted under the EU's decentralized procedure, with the U.K. acting as the reference member state. Novalar expects a decision on the application in mid-2011. ...